Literature DB >> 24026659

Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.

Shun-Jun Fu1, Shun-Li Shen, Shao-Qiang Li, Yun-Peng Hua, Wen-Jie Hu, Li-Jian Liang, Bao-Gang Peng.   

Abstract

Neutrophil-to-lymphocyte ratio (NLR), an inflammation index, is considered a prognostic predictor of hepatocellular carcinoma (HCC). This study aimed to evaluate the prognostic value of preoperative peripheral NLR in patients with hepatitis B virus (HBV)-associated HCC after radical hepatectomy. Clinical data were collected from patients with HBV-associated HCC who underwent radical hepatectomy. NLR was calculated from lymphocyte and neutrophil counts on preoperative routine blood tests. Demographics, laboratory analyses, and histopathological data were analyzed. A total of 282 patients were selected and divided by the cutoff NLR value of 2. Multivariate analysis showed that NLR > 2 was an independent prognostic predictor of poor disease-free survival [hazard ratio (HR) = 1.362; 95% confidence interval (CI) 1.025-1.811; P = 0.033] and overall survival (HR = 1.434; 95% CI 1.044-1.970; P = 0.023). NLR had a good predictive value for prognosis in patients with HBV-associated HCC who had normal serum AFP level. These results suggested that NLR is an independent indicator of both disease-free survival and overall survival in patients with HBV-associated HCC after radical hepatectomy, including AFP-normal patients.

Entities:  

Mesh:

Year:  2013        PMID: 24026659     DOI: 10.1007/s12032-013-0721-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  40 in total

1.  Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.

Authors:  Karim J Halazun; Mark A Hardy; Abbas A Rana; David C Woodland; Elijah J Luyten; Suhari Mahadev; Piotr Witkowski; Abbey B Siegel; Robert S Brown; Jean C Emond
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

2.  Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma.

Authors:  G Garcea; N Ladwa; C P Neal; M S Metcalfe; A R Dennison; D P Berry
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

3.  Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

Authors:  Mi Ran Jung; Young Kyu Park; Oh Jeong; Jang Won Seon; Seong Yeob Ryu; Dong Yi Kim; Young Jin Kim
Journal:  J Surg Oncol       Date:  2011-05-25       Impact factor: 3.454

4.  Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes.

Authors:  H T Petrie; L W Klassen; H D Kay
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.

Authors:  Fu Yang; Ling Zhang; Xi-song Huo; Ji-hang Yuan; Dan Xu; Sheng-xian Yuan; Nan Zhu; Wei-ping Zhou; Guang-shun Yang; Yu-zhao Wang; Jing-li Shang; Chun-fang Gao; Feng-rui Zhang; Fang Wang; Shu-han Sun
Journal:  Hepatology       Date:  2011-09-06       Impact factor: 17.425

6.  Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.

Authors:  P Shamamian; J D Schwartz; B J Pocock; S Monea; D Whiting; S G Marcus; P Mignatti
Journal:  J Cell Physiol       Date:  2001-11       Impact factor: 6.384

7.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

Authors:  D Gomez; S Farid; H Z Malik; A L Young; G J Toogood; J P A Lodge; K R Prasad
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

8.  Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma.

Authors:  O K Idowu; Q Ding; A F G Taktak; C R Chandrasekar; Q Yin
Journal:  Biomarkers       Date:  2012-07-16       Impact factor: 2.658

9.  A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.

Authors:  Guo-Ying Wang; Yang Yang; Hua Li; Jian Zhang; Nan Jiang; Min-Ru Li; Huan-Bing Zhu; Qi Zhang; Gui-Hua Chen
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

10.  p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.

Authors:  C Fondevila; J P Metges; J Fuster; J J Grau; A Palacín; A Castells; A Volant; M Pera
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  31 in total

1.  Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.

Authors:  Hao-Jie Yang; Zhe Guo; Yu-Ting Yang; Jing-Hang Jiang; Ya-Peng Qi; Ji-Jia Li; Le-Qun Li; Bang-De Xiang
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.

Authors:  Shan-Shan Wu; Quan-Yuan Shan; Wen-Xuan Xie; Bin Chen; Yang Huang; Yu Guo; Xiao-Yan Xie; Ming-De Lu; Bao-Gang Peng; Ming Kuang; Shun-Li Shen; Wei Wang
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

3.  Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Ze-Xiao Lin; Dan-Yun Ruan; Yang Li; Dong-Hao Wu; Xiao-Kun Ma; Jie Chen; Zhan-Hong Chen; Xing Li; Tian-Tian Wang; Qu Lin; Jing-Yun Wen; Xiang-Yuan Wu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

4.  Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib.

Authors:  Kai Wei; Meng Wang; Wei Zhang; Han Mu; Tian-Qiang Song
Journal:  Med Oncol       Date:  2014-05-04       Impact factor: 3.064

5.  Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis.

Authors:  Fangyu Yang; Qianyi Huang; Zhongying Guan; Qizhi Diao
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-04       Impact factor: 2.503

6.  Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment.

Authors:  Puo-Hsien Le; Kung-Hao Liang; Ming-Ling Chang; Chao-Wei Hsu; Yi-Cheng Chen; Chih-Lang Lin; Wey-Ran Lin; Ming-Wei Lai; Chau-Ting Yeh
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

7.  Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.

Authors:  Dong-Sheng Zhou; Li Xu; Yao-Ling Luo; Feng-Ying He; Jun-Ting Huang; Yao-Jun Zhang; Min-Shan Chen
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

8.  Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.

Authors:  Xing Li; Zhan-Hong Chen; Xiao-Kun Ma; Jie Chen; Dong-Hao Wu; Qu Lin; Min Dong; Li Wei; Tian-Tian Wang; Dan-Yun Ruan; Ze-Xiao Lin; Yan-Fang Xing; Yun Deng; Xiang-Yuan Wu; Jin-Yun Wen
Journal:  Tumour Biol       Date:  2014-08-06

9.  Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.

Authors:  Keisuke Arai; Takumi Fukumoto; Masahiro Kido; Motofumi Tanaka; Kaori Kuramitsu; Hisoka Kinoshita; Shohei Komatsu; Daisuke Tsugawa; Sachio Terai; Taku Matsumoto; Tadahiro Goto; Sadaki Asari; Hirochika Toyama; Tetsuo Ajiki; Yonson Ku
Journal:  Surg Today       Date:  2016-07-27       Impact factor: 2.549

10.  Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Shunjun Fu; Zhiyong Guo; Shaoqiang Li; Ming Kuang; Wenjie Hu; Yunpeng Hua; Xiaoshun He; Baogang Peng
Journal:  Tumour Biol       Date:  2015-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.